AzTrials
AzTrials

DepressionNCT05914025

The Effect of a Brief Online Behavioral Activation Intervention

A study testing Behavioral Activation in people with Depression, run by Palo Alto University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Depression is a worldwide phenomena that has a severe personal, social and societal impact. One such impact is an over $200 billion worldwide economic cost. While many treatments exist for depression, many individuals may not receive the support that they need for reasons such as stigma, financial restraints, or… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Depression
What is being tested?
Behavioral Activation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
106 participants
Where
1 siteUnited States
Study dates
24 Jan 2022to 18 Apr 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 18 years of age or older
  • United States Resident

Who cannot join

  • Non-US resident
  • Younger than 18 years old

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Online Recruitment/Palo Alto University Campus

    Palo Alto, California, 94304

Other trials in United States

About this study

Official title: The Effect of a Brief Online Behavioral Activation Intervention by Activity Type

Depression is a worldwide phenomena that has a severe personal, social and societal impact. One such impact is an over $200 billion worldwide economic cost. While many treatments exist for depression, many individuals may not receive the support that they need for reasons such as stigma, financial restraints, or limited access to therapists. As such, it is important to assess the efficacy of brief online treatments as an alternative to full length, in-person treatments. A series of studies looking at a brief behavioral activation for depression treatment has shown that participants have reported temporarily improved mood, confidence, motivation and reduced depressive symptoms. It is important to test this treatment in multiple groups of people to acquire additional information regarding brief online interventions. This study seeks to collect participants from online social media sources and compare results to historical data that were collected from a prior research study which used Amazon Mechanical Turk as a recruitment source.

Conditions
Depression
Being tested
Behavioral Activation
Medical subject headings
Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Behavioral ActivationBehavioural

    Individuals will be provided with information about maladaptive patterns of behavior and how to correct these cycles with activity scheduling to elicit more positive emotional experiences. Participants will be provided with categories/lists of activities and a downloadable calendar after receiving the psychoeducation.

Study groups in NCT05914025
Study groupRoleWhat they receive
Behavioral Activation InterventionExperimentalAll individuals enrolled in the study will be assigned to this arm and will receive a brief behavioral activation psychoeducation module among other self-report assessments.
Receives: Behavioral: Behavioral Activation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Depression level

    Changes in depression score as measured by the PROMIS scale. The PROMIS is scored on a 5-point Likert scale with responses 1 to 5 corresponding to Never, Rarely, Sometimes, Often, and Always respectively.

    Measured: 3 days

  2. Self-reported mood

    Changes in mood as measured by a self-reported mood question. This measure is scored on a 9-point Likert scale (1 = Extremely Negative to 9 = Extremely Positive)

    Measured: 3 days

  3. Daily Enjoyment

    Changes in enjoyment as measured by a self-reported question around daily enjoyment. This measure is scored on a 5-point Likert scale (1 = Not at all to 9 = Extremely)

    Measured: At time of original survey

Secondary outcomes (1)
  1. Confidence, Motivation, and Usefulness

    Changes in confidence, motivation, and usefulness are measured with single self-reported measures for confidence, motivation, and usefulness of the intervention. They are rated on a 9 point Likert scale (1 = Extremely Negative to 9 = Extremely Positive)

    Measured: 3 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jun 2023
  2. Study start24 Jan 2022
  3. Primary completion20 Feb 2023
  4. Study completion18 Apr 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
106 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05914025
Sponsor's protocol ID
2021-082
Status last verified
Jun 2023
First submitted
2 Feb 2022
Last updated
22 Jun 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Behavioral Activation in people with Depression, run by Palo Alto University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Depression level (time frame: 3 days). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jun 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in